Callio Therapeutics

Last updated: November 17, 2025

CEO - Piers Ingram

Country: USA | Funding: $187M (+)
Founded: 2024

Website: https://calliotx.com/

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

Competitors

BioNTech

Artios Pharma

Acepodia